Published in Curr Drug Targets on December 01, 2009
EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. Clin Transl Allergy (2012) 1.04
A DNA vaccine encoding a chimeric allergen derived from major group 1 allergens of dust mite can be used for specific immunotherapy. Int J Clin Exp Pathol (2014) 0.76
Role of contact sensitization in chronic urticaria. J Am Acad Dermatol (2006) 2.22
Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009-2012. Ann Allergy Asthma Immunol (2013) 2.15
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. World Allergy Organ J (2010) 2.01
Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Curr Med Res Opin (2013) 1.92
Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest (2007) 1.84
Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009. Allergy (2009) 1.65
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. Pediatr Allergy Immunol (2010) 1.58
A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis. Clin Ther (2005) 1.45
Why do doctors and patients not follow guidelines? Curr Opin Allergy Clin Immunol (2009) 1.35
Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. J Allergy Clin Immunol (2013) 1.33
Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol (2006) 1.26
Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. J Child Neurol (2011) 1.13
Possible role of climate changes in variations in pollen seasons and allergic sensitizations during 27 years. Ann Allergy Asthma Immunol (2010) 1.13
The link between allergic rhinitis and asthma: the united airways disease. Expert Rev Clin Immunol (2010) 1.11
Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol (2007) 1.11
The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms. Clin Biochem (2011) 1.08
Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol (2010) 1.06
Bridging allergologic and botanical knowledge in seasonal allergy: a role for phenology. Ann Allergy Asthma Immunol (2010) 1.04
Sub-lingual immunotherapy: world allergy organization position paper 2009. World Allergy Organ J (2009) 1.03
Application of GRADE: making evidence-based recommendations about diagnostic tests in clinical practice guidelines. Implement Sci (2011) 1.02
Perturbations of natural killer cell regulatory functions in respiratory allergic diseases. J Allergy Clin Immunol (2007) 0.98
Clara cell 16 protein in COPD sputum: a marker of small airways damage? Respir Med (2007) 0.97
How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers' viewpoint. J Allergy Clin Immunol (2010) 0.94
Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses. Ann Allergy Asthma Immunol (2009) 0.93
Beta₂-agonists for exercise-induced asthma. Cochrane Database Syst Rev (2013) 0.92
Allergic diseases and their impact on quality of life. Ann Allergy Asthma Immunol (2006) 0.92
Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol (2004) 0.90
Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha. Eur J Immunol (2002) 0.89
Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications. Expert Rev Vaccines (2013) 0.89
Asthma management failure: a flaw in physicians' behavior or in patients' knowledge? J Asthma (2011) 0.88
GRADE system: new paradigm. Curr Opin Allergy Clin Immunol (2010) 0.88
New insights into airway remodelling in asthma and its possible modulation. Curr Opin Allergy Clin Immunol (2008) 0.87
New directions in immunotherapy. Curr Allergy Asthma Rep (2013) 0.86
Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study. Ann Allergy Asthma Immunol (2006) 0.86
Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990-1999). Respir Med (2005) 0.86
Disability in COPD and its relationship to clinical and patient-reported outcomes. Curr Med Res Opin (2011) 0.86
Patient knowledge, perceptions, expectations and satisfaction on allergen-specific immunotherapy: a survey. Respir Med (2012) 0.86
Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper. World Allergy Organ J (2010) 0.85
Office spirometry can improve the diagnosis of obstructive airway disease in primary care setting. Respir Med (2009) 0.84
Harmful effect of immunotherapy in children with combined snail and mite allergy. J Allergy Clin Immunol (2002) 0.84
The clinical characteristics of respiratory allergy in immigrants in northern Italy. Int Arch Allergy Immunol (2008) 0.84
Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers. Int Arch Allergy Immunol (2005) 0.84
A review of the use of fluticasone furoate since its launch. Expert Opin Pharmacother (2011) 0.84
Clinical and cytologic characteristics of allergic rhinitis in elderly patients. Ann Allergy Asthma Immunol (2012) 0.84
Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system. Curr Opin Allergy Clin Immunol (2010) 0.83
Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. J Am Acad Dermatol (2003) 0.83
Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study. J Allergy Clin Immunol (2005) 0.83
Patients with asthma and comorbid allergic rhinitis: is optimal quality of life achievable in real life? PLoS One (2012) 0.83
Sublingual immunotherapy for allergic rhinitis and conjunctivitis. Immunotherapy (2013) 0.83
The possible influence of the environment on respiratory allergy: a survey on immigrants to Italy. Ann Allergy Asthma Immunol (2011) 0.83
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco. Int Arch Allergy Immunol (2012) 0.83
When allergic rhinitis is not only allergic. Am J Rhinol Allergy (2009) 0.82
Chronic obstructive pulmonary disease patient well-being and its relationship with clinical and patient-reported outcomes: a real-life observational study. Respiration (2011) 0.82
Serum cytotoxic T lymphocyte-associated antigen 4 in Hymenoptera venom allergy and its modulation by specific immunotherapy. J Allergy Clin Immunol (2008) 0.82
Biomarker discovery in asthma and COPD by proteomic approaches. Proteomics Clin Appl (2014) 0.82
Allergy training and immunotherapy in Latin America: results of a regional overview. Ann Allergy Asthma Immunol (2013) 0.82
The relationship between asthma control and quality-of-life impairment due to chronic cough: a real-life study. Ann Allergy Asthma Immunol (2008) 0.82
Airway remodelling in children: when does it start? Curr Opin Allergy Clin Immunol (2007) 0.81
The management of paediatric allergy: not everybody's cup of tea--10-11th February 2012. Curr Opin Allergy Clin Immunol (2013) 0.81
Impact of bariatric surgery on pulmonary function and nitric oxide in asthmatic and non-asthmatic obese patients. J Asthma (2011) 0.81
Molecular allergy diagnosis: we need to become more knowledgeable. Ann Allergy Asthma Immunol (2012) 0.81
The added value of allergen microarray technique to the management of poly-sensitized allergic patients. Curr Opin Allergy Clin Immunol (2012) 0.81
Component-resolved diagnosis in pediatric allergic rhinoconjunctivitis and asthma. Curr Opin Allergy Clin Immunol (2013) 0.81
The safety of allergen specific sublingual immunotherapy. Curr Drug Saf (2007) 0.81
Safety and tolerability of sublingual immunotherapy in clinical trials and real life. Curr Opin Allergy Clin Immunol (2013) 0.80
Oral and sublingual immunotherapy in paediatric patients. Curr Opin Allergy Clin Immunol (2003) 0.80
Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules. J Allergy Clin Immunol (2003) 0.80
Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy. Ann Allergy Asthma Immunol (2008) 0.80
Focus on cat allergen (Fel d 1): immunological and aerodynamic characteristics, modality of airway sensitization and avoidance strategies. Int Arch Allergy Immunol (2003) 0.80
Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. Respir Res (2013) 0.80
Eosinophilic esophagitis: which role for food and inhalant allergens? Asia Pac Allergy (2012) 0.80
Cross-sectional comparison of the characteristics of respiratory allergy in immigrants and Italian children. Pediatr Allergy Immunol (2014) 0.80
Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study. Curr Med Res Opin (2008) 0.80
Emerging drugs for allergic conjunctivitis. Expert Opin Emerg Drugs (2014) 0.80
Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire. Ann Allergy Asthma Immunol (2011) 0.79
Non-injection routes for allergen immunotherapy: focus on sublingual immunotherapy. Inflamm Allergy Drug Targets (2006) 0.79
Emerging sublingual immunotherapy drugs. Expert Opin Pharmacother (2010) 0.79
Sublingual immunotherapy: update 2006. Curr Opin Allergy Clin Immunol (2006) 0.79
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. Immunol Lett (2012) 0.79
Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes. J Asthma (2010) 0.78
An update on the asthma-rhinitis link. Curr Opin Allergy Clin Immunol (2004) 0.78
May we strengthen the human natural defenses with bacterial lysates? World Allergy Organ J (2010) 0.78
The role of Pneumococcal vaccine. Pulm Pharmacol Ther (2008) 0.78
Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety. Expert Rev Clin Immunol (2014) 0.78
Sublingual immunotherapy for allergic rhinitis: an update. Curr Opin Otolaryngol Head Neck Surg (2011) 0.78
Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum CTLA-4 and IL-10. PLoS One (2012) 0.78
Sublingual immunotherapy: other indications. Immunol Allergy Clin North Am (2011) 0.78
Efficacy and safety of sublingual immunotherapy. Ann Allergy Asthma Immunol (2004) 0.77
A model of allergen-driven human airway contraction: beta2 pathway dysfunction without cytokine involvement. Ann Allergy Asthma Immunol (2005) 0.77
Levocetirizine in the treatment of allergic diseases. Expert Opin Pharmacother (2009) 0.77
Long-acting bronchodilators improve health related quality of life in patients with COPD. Respir Med (2013) 0.77
Randomized open comparison of the safety of SLIT in a no-updosing and traditional updosing schedule in patients with Parietaria allergy. Allergol Immunopathol (Madr) (2006) 0.77